Current Affairs

DCGI given nod to Mylan pharma to launch Remdesivir


Daily Current Affairs

DCGI given nod to Mylan pharma to launch Remdesivir

Key highlights:

Drug controller and General of India has given its approval to Mylan Pharma, a major pharmaceutical to launch Desrem,  a coronavirus general drug to be used on patients of suspected or laboratory-confirmed severe incidences of COVID19 in adults and children.

Desrem is a version of remdesivir allowed to use for sever incidences of covid19

Mylan’s similar version has already been launched by Cipla ltd and privately held hetero labs ltd.

Cipla's price will range up to 5000 rupees, cipremi will price 5000 rupees, while Hetero has priced its version, Covifor at 5400 rupees.

Daily Current Affairs

Also Read Current Affairs in Tamil, Current Affairs in English, Download Current pdf in Tamil, Download Current Affairs in English, Upcoming Jobs            

DCGI given nod to Mylan pharma to launch Remdesivir